COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH CONVENTIONAL THERAPY IN PATIENTS WITH CROHN'S DISEASE IN THE UNITED KINGDOM (UK)

被引：0
|
作者：
Robson, R. E. [1 ]
Vanoli, A. [2 ]
Tolley, K. [3 ]
机构：
[1] Tolley Hlth Econ, Buxton, England
[2] CEMOR Med Ltd, Newcastle Upon Tyne, Tyne & Wear, England
[3] Tolley Hlth Econ Ltd, Buxton, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2689
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY114
引用
收藏
页码：S455 / S456
页数：3
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF SCREENING AND TREATMENT OF ALZHEIMER'S DISEASE WITH DONEPEZIL IN THE UNITED KINGDOM
    Getsios, D.
    Blume, S.
    Ishak, K. J.
    MacLaine, G.
    VALUE IN HEALTH, 2009, 12 (03) : A191 - A191
  • [22] COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH INFLIXIMAB, ADALIMUMAB, AND GOLIMUMAB FOR TREATMENT OF MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS IN THE UNITED KINGDOM
    Wilson, M.
    Kerrigan, M.
    Smyth, M.
    Chevrou-Severac, H.
    Bergman, A.
    Selby, R.
    GUT, 2016, 65 : A260 - A261
  • [23] Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
    Loftus, Edward V., Jr.
    Johnson, Scott J.
    Yu, Andrew P.
    Wu, Eric Q.
    Chao, Jingdong
    Mulani, Parvez M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1302 - 1309
  • [24] Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients
    Chen, Nai-Yu
    Chiu, Yung-Ting
    Chuang, Chiao-Hsiung
    Chang, Yu-Ching
    Cheng, Ching-Lan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 356 - 356
  • [25] Cost-effectiveness of reducing radiation in Crohn's disease
    Lena B. Palmer
    Nature Reviews Gastroenterology & Hepatology, 2011, 8 : 664 - 665
  • [26] COST-EFFECTIVENESS OF SEQUENCING VEDOLIZUMAB AS FIRST-LINE BIOLOGIC IN ULCERATIVE COLITIS AND CROHN'S DISEASE IN CANADA
    Fischer, A.
    Mac, S.
    Freiman, E.
    Marshall, J.
    Rand, K.
    Ramos-Goni, J. M.
    VALUE IN HEALTH, 2023, 26 (12) : S84 - S84
  • [27] Cost-effectiveness of statin therapy in categories of patients in the UK
    Mihaylova, B.
    Wu, R.
    Williams, C.
    Zhou, J.
    Schlackow, I.
    Emberson, J.
    Reith, C.
    Keech, A.
    Robson, J.
    Wilkinson, K.
    Armitage, J.
    Collins, R.
    Gray, A.
    Simes, J.
    Baigent, C.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2841 - 2841
  • [28] Cost-effectiveness of Nonmelanoma Skin Cancer Screening in Crohn's Disease Patients
    Okafor, Philip N.
    Stallwood, Christopher G.
    Nguyen, Linda
    Sahni, Debjani
    Wasan, Sharmeel K.
    Farraye, Francis A.
    Erim, Daniel O.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (13) : 2787 - 2795
  • [29] Cost-Effectiveness of Nonmelanoma Skin Cancer Screening in Crohn's Disease Patients
    Okafor, Philip N.
    Stallwood, Christopher G.
    Nguyen, Linda T.
    Sahni, Debjani
    Cummins, Deborah L.
    Wasan, Sharmeel K.
    Farraye, Francis A.
    Erim, Daniel O.
    GASTROENTEROLOGY, 2013, 144 (05) : S216 - S216
  • [30] The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease
    Macaluso, F. S.
    Grova, M.
    Saladino, M.
    Demarzo, M. G.
    Privitera, A. C.
    Giangreco, E.
    Garufi, S.
    Renna, S.
    Casa, A.
    Ventimiglia, M.
    Cappello, M.
    Fries, W.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I359 - I359
12345